Display options
Cite
Gisselbrecht C. Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?. Oncology (Williston Park). 2012;26(5)
Gisselbrecht, C. (2012). Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?. Oncology (Williston Park, N.Y.), 26(5), .
Gisselbrecht, Christian. "Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?." Oncology (Williston Park, N.Y.) vol. 26,5 (2012).
Gisselbrecht C. Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?. Oncology (Williston Park). 2012 May 15;26(5). PMID: 25192143.
Copy Download .nbib Format: NLM
Share it on

Oncology (Williston Park). 2012 May 15;26(5).

Is Dose-Dense Therapy Effective Against DLBCL in the Era of Rituximab?.

Oncology (Williston Park, N.Y.)

Christian Gisselbrecht

PMID: 25192143

[No abstract available.]

Publication Types